Microperimetry as a routine diagnostic test in the follow-up of retinal vein occlusion?

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 2, 2012, Pages 175-183

  Winterhalter, Sibylle ^a   Lux, Anja ^b   Maier, Anna Karina ^a   Scholz, Clara ^c   Heußen, Florian M A ^a   Huber, Klaudia K ^b   Joussen, Antonia M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c HELIOS KLINIKUM WUPPERTAL   (Germany)

Author keywords

Anti VEGF; Macular disease; Microperimetry; Retinal vein occlusion

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETATE;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LASER COAGULATION; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PERIMETRY; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; SENSITIVITY ANALYSIS; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DIAGNOSTIC TESTS, ROUTINE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MALE; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; SCOTOMA; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84857363999     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1784-8     Document Type: Article

References (17)

1. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S (2006) ANCHOR study group: ranibizumab vs. verteporfin for neovascular age-relatedmacular degeneration. N Engl J Med 355:1432-1444 (Pubitemid 44511558)
2. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY (2006) Ranibizumab for age-related macular generation. MARINA study. N Engl J Med 355:1419-1431 (Pubitemid 44511557)
3. Massin P, Bandello F, Garweg JG, Hanssen LL, Harding SP, Larsen M, Mitchell P, Scharp D,Wolf Schnurrbusch UE, Gekkieva M, Weichselberger A, Wolf S (2010) Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 33(11):2399-2405
4. Nicholson BP, Schachat AP (2010) A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 248(7):915-930
5. Kampik A, Priglinger S (2008) Intravitreal bevacizumab for the treatment of macular oedema secondary to branch vein occlusion. Br J Ophthalmol 92:351-355 (Pubitemid 351363529)
6. Jaissle GB, Leitritz M, Gelisken F (2009) One-year results after intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 247:27-33
7. Kiss CG, Barisani-Asenbauer T, Simader C, Maca S, Schmidt-Erfurth U (2008) Central visual field impairment during and following cystoid macular oedema. Br J Ophthalmol 92:84-88
8. Rohrschneider K, Bueltmann S, Springer C (2008) Use of fundus perimetry (microperimetry) to quantify macular sensitivity. Prog Retinal Eye Res 27:536-548
9. Ferris FL, Kassoff A, Bresnick GH, Bailey I (1982) New visual acuity charts for clinical research. Am J Ophthalmol 94:91-96 (Pubitemid 12080556)
10. Radner W, Willinger U, Obermayer W (1998) Eine neue Lesetafel zur gleichzeitigen Bestimmung von Lesevisus und Lesegeschwindigkeit. Klin Monatsbl Augenheilkd 213:174-181 (Pubitemid 28460072)
11. Stifter E, Konig F, Lang T, Bauer P, Richter-Müksch S, Velikay-Parel M, Radner W (2004) Reliability of a standardized reading chart system: variance component analysis, testretest and inter-chart reliability. Graefes Arch Clin Exp Ophthalmol 242:31-39 (Pubitemid 38208282)
12. Morwood SL (2000) Research strategies for advanced practice nurses. Prentice Hall Health, New Jersey
13. du Prel JB, Hommel G, Röhrig B, Blettner M (2009) Confidence interval or p-value?: part 4 of a series on evaluation of scientific publications. Dtsch Arztebl Int 106(19):335-339
14. Ach T, Hoch A, Schaal K, Scheuerle AF, Dithmar S (2009) Predictive factors for changes in macular edema in intravitreal bevacizumab therapy for retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. doi:10.1007/s00417- 009-1167-6
15. Kriechbaum K, Prager F, Geitzenauer W, Benesch T, Schütze C, Simader C, Schmidt-Erfurth U (2009) Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year. Opthalmology 116:2415-2421
16. Senturk F, Ozdemir H, Karacorlu M, Karacorlu S, Uysal O (2010) Mircoperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion. Retina 30:1254-1261
17. Midena E, St V, Convento E, Manfré A, Cavarzeran F, Pilotto E (2007) Microperimetry and fundus autofluorescence in patients with early age- related macular degeneration. Br J Ophthalmol 91:1499-1503 (Pubitemid 350044055)